DiamiR Announces Oral Presentation at AD/PD™ 2017

MONMOUTH JUNCTION, NJ–(Marketwired – March 29, 2017) – DiamiR, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, today announced that Samuil Umansky, MD, PhD, Chief Scientific Officer, will be presenting at The 13th International Conference on Alzheimer’s & Parkinson’s Diseases (AD/PD™ 2017) being held March 29 – April 2, 2017 in Vienna, Austria.